 SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores
SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores
Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores
Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores
IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores
Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores 
              Bombay Stock Exchange has announced that effective from October 19, 2007, the equity shares of Saamya Biotech India Ltd (Scrip Code: 532905) shall listed and admitted to dealings on the Exchange in the list of 'B1' Group Securities.
The company issued shares at a price of Rs.10 Per share (Face Value of Rs. 10/-) in the recently concluded IPO.
The ISIN Code of the company is INE320H01019.
Aarthi Consultants Private Limited is the Registrar to the issue.
DHIREN HASMUKHLAL VORA, PARK LIGHT INVESTMENT PRIVATE LIMITED, DEEP INFRASTRUCTURE PVT. LTD, MR. ASHVIN SOMCHAND SHETH, HARSHA RAJESH JHAVERI, VICKY R JHAVERI, PARMANAND GANPATRAM KHANDWALA, ELEGANT PROJECTS PVT LTD and RUPESH BALVANTBHAI BRAHMBHATT are the major shareholders of the company under Public Category.